Dermatology News: 2007.28

• 2007.28(10) Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: Effects on T-cell infiltration, epidermal proliferation and keratinisation
  Selective photothermolysis of diseased capillaries by pulsed dye laser (PDL) treatment has been described as a mechanism for long-lasting clearance of psoriatic plaques...   |   Read more ...



• 2007.28(9) Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: Patient-reported outcomes from a Phase II randomized controlled trial
  Psoriasis substantially impairs the health-related quality of life (HRQOL) of patients, and a comprehensive evaluation of treatment includes HRQOL measures...   |   Read more ...



• 2007.28(8) Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria
  H1 receptor antagonists are the mainstay of treatment for chronic idiopathic urticaria. Newer hydroxyzine derivatives such as cetirizine and levocetirizine have been found to be equally efficacious in preclinical studies in patients with chronic idiopathic urticaria...   |   Read more ...



• 2007.28(7) Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel®) for up to 1 year
  To determine blood concentrations of pimecrolimus after long-term intermittent administration of pimecrolimus cream 1% in adult patients with extensive atopic dermatitis (AD)...   |   Read more ...



• 2007.28(6) Alefacept in corticosteroid refractory graft versus host disease: Early results indicate promising activity
  Steroid refractory graft versus host disease (GVHD) presents a significant therapeutic challenge due to the limited efficacy and safety of second-line treatments...   |   Read more ...



• 2007.28(5) Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment
  We investigated the impact of diabetes mellitus type 2, overweight, alcohol over-consumption, and chronic hepatitis B or C as risk factors, for liver fibrosis in psoriasis patients treated with methotrexate...   |   Read more ...



• 2007.28(4) Loss of vaccine-induced immunity to varicella over time
  The introduction of universal varicella vaccination in 1995 has substantially reduced varicella-related morbidity and mortality in the United States...   |   Read more ...



• 2007.28(3) FDA Approves Antibiotic Ointment for Children and Adults
  The Food and Drug Administration (FDA) approved Altabax (retapamulin ointment) for topical treatment of impetigo (http://www.nlm.nih.gov/medlineplus/impetigo.html), a skin infection caused by bacteria...   |   Read more ...



• 2007.28(2) Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
  Most patients with melanoma have microscopically thin (< or = 1 mm) primary lesions and are cured with excision. However, some develop metastatic disease that is often fatal...   |   Read more ...



• 2007.28(1) Beneficial Long-Term Effects of Combined Oral/Topical Antioxidant Treatment with the Carotenoids Lutein and Zeaxanthin on Human Skin: A Double-Blind, Placebo-Controlled Study
  The skin is exposed to numerous environmental assaults that can lead to premature aging...   |   Read more ...

    Current Year Archive:   Dermatology News 2007   |   Main Archive:   Dermatology News  

The Derm News service provided by the Editorial Consultants of Skin Therapy Letter^© and its founding editor Dr. Stuart Maddin.